Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RECORA- Regorafenib in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy.

NCT01959269 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01959269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01959269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RECORA- Regorafenib in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy.
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
October 31, 2013
Completion date
July 7, 2017
Enrollment
483 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal neoplasm